Inflammation

Items 791-800 of 1122

per page
Set Descending Direction
  1. anti-HMGB1, mAb (rec.) (Giby-1-4)
    AG-27B-0002
    AG-27B-0002-C100100 µg
    CHF 350.00
    Western blot analysis of human and rat HMGB1 using anti-HMGB1, mAb (rec.) (GIBY-1-4) (Prod. No. AG-27B-0002)
Different amounts of cell extracts from HEK293T cells (3μg, 5μg and 30μg) either transfected with a plasmid coding for rat HMGB1 (l
  2. anti-HMGB1, mAb (rec.) (Giby-1-4) (Biotin)
    AG-27B-0002B
    AG-27B-0002B-C100100 µg
    CHF 395.00
    anti-HMGB1, mAb (rec.) (Giby-1-4) (Biotin)
  3. anti-IDO1 (human), mAb (ID 177)
    AG-20A-0035
    AG-20A-0035-C05050 µg
    CHF 270.00
    AG-20A-0035-C100100 µg
    CHF 350.00
    Immunohistochemical staining of IDO using anti-IDO (human), mAb (ID 177) (Prod. No. AG-20A-0035) in human placenta tissue (10µg/ml). This antibody has been tested in immunohistochemistry, analyzed by an anatomic pathologist and validated for u
  4. anti-IDO1 (human), pAb
    AG-25A-0029
    AG-25A-0029-C100100 µg
    CHF 450.00
    Immunocytochemistry fluorescent staining of human mature dendritic cells using anti-IDO (human), pAb (Prod. No. AG-25A-0029).
  5. anti-IDO1 (mouse), pAb
    AG-25A-0032
    AG-25A-0032-C100100 µg
    CHF 450.00
    Immunohistochemical staining of mouse gut using anti-IDO (mouse), pAb (Prod. No. AG-25A-0032). Colorization by ABS Reagent (Vectastain) and counterstaining with hematoxylin.
  6. anti-IFN-γ (human), mAb (ANC2E11)
    ANC-247-020.
    ANC-247-020100 µg
    CHF 260.00
  7. anti-IFN-γ (human), mAb (ANC2E11) (Biotin)
    ANC-247-030.
    ANC-247-030100 µg
    CHF 306.00
  8. anti-IFN-γ (human), mAb (ANC2E11) (FITC)
    ANC-247-040.
    ANC-247-040120 tests
    CHF 306.00
  9. anti-IFN-γ (human), mAb (ANC2E11) (R-PE)
    ANC-247-050.
    ANC-247-050120 tests
    CHF 390.00
  10. anti-Igκ (human), mAb (L1C1)
    ANC-136-020.
    ANC-136-020100 µg
    CHF 260.00

Items 791-800 of 1122

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.